Novo Nordisk relocates data management from Singapore to India

By Kirsty Barnes

- Last updated on GMT

Related tags Data management

Novo Nordisk is in the process of relocating its clinical data
management centre to India after closing down the operation in
Singapore, where it had been previously run for many years.

The company's data management exit from Singapore was due to the closing of its clinical development centre in the country, which has now moved to Beijing, on the heels of the head of the team who wanted to make the move. "Now that we no longer have a clinical development centre in Singapore we decided to move the data management function to India where we feel there is more experience in this field,"​ company spokesperson Anne Prener told The Danish biopharma giant already has an office in Bangalore, where the centre will now be located. Until now the firm only had sales and marketing staff located at this site, along with a small team conducting data management for local clinical trials. "We are currently running a number of trials in India,"​ said Prener. Soon, however, data management for Novo's global trials from 60 countries across the Asia-Pacific (excluding Japan), Africa and Latin America will be done from this new location. Recruitment is underway now for around 20 new staff at the site, as the company's data management employees at the former site in Singapore did not relocate. At this point, the company has no further expansion plans in India, said Prener. Meanwhile, Novo's existing relationship with Indian IT service firm Tata Consultancy Services (TCS) remains unchanged, she said. TCS has been working with the company in India for a number of years assisting the company with the data management of its clinical trials run in India, on an "overflow basis."​ Novo Nordisk is one of a growing number of biopharma firms who have been actively implementing an outsourcing strategy as a cost-cutting and time saving measure and also has number of other such agreements in place in India.

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more